STOCK-BASED COMPENSATION (Tables)
|
3 Months Ended |
Mar. 31, 2024 |
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of weighted-average assumptions used to estimate fair value of restricted stock units |
Inputs and assumptions used to calculate the fair value are shown in the table below. The fair value of these RSUs is expensed over the vesting period using the straight-line method or using the graded vesting method when an employee becomes eligible to retain the award at retirement. | | | | | | | | | | | | | Three Months Ended March 31, | 2024 | | 2023 | | Fair value per stock award | $ | 145.79 | | | $ | 116.17 | | | Grant date stock price | $ | 141.00 | | | $ | 111.38 | | | Assumptions: | | | | | Aptar's stock price expected volatility | 18.80 | % | | 20.00 | % | | Expected average volatility of peer companies | 34.80 | % | | 39.70 | % | | Correlation assumption | 30.70 | % | | 33.30 | % | | Risk-free interest rate | 4.51 | % | | 3.83 | % | | Dividend yield assumption | 1.16 | % | | 1.36 | % |
|
| Schedule of restricted stock unit activity |
A summary of RSU activity as of March 31, 2024 and changes during the three month period then ended is presented below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Time-Based RSUs | | Performance-Based RSUs | | Units | | Weighted Average Grant-Date Fair Value | | Units | | Weighted Average Grant-Date Fair Value | | Nonvested at January 1, 2024 | 335,874 | | | $ | 115.15 | | | 514,383 | | | $ | 130.10 | | | Granted | 101,067 | | | 135.60 | | | 129,540 | | | 145.79 | | | Vested | (144,668) | | | 122.38 | | | (642) | | | 130.10 | | | Forfeited | (1,466) | | | 116.94 | | | (2,294) | | | 133.41 | | | Nonvested at March 31, 2024 | 290,807 | | | $ | 118.43 | | | 640,987 | | | $ | 133.26 | |
|
| Schedule of compensation expense, fair value, and intrinsic value related to RSU's |
| | | | | | | | | | | | | Three Months Ended March 31, | 2024 | | 2023 | | Compensation expense | $ | 13,985 | | | $ | 12,071 | | | Fair value of units vested | 16,319 | | | 14,587 | | | Intrinsic value of units vested | 20,246 | | | 17,046 | |
|
| Schedule of share-based payment award, stock options, valuation assumptions |
These values were estimated on the respective dates of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions: | | | | | | | | | | | | | Stock Award Plans: | | | | | Three Months Ended March 31, | 2024 | | 2023 | | Dividend Yield | 1.28 | % | | 1.41 | % | | Expected Stock Price Volatility | 17.03 | % | | 16.55 | % | | Risk-free Interest Rate | 4.51 | % | | 3.57 | % | | Expected Life of Option (years) | 7.0 | | 7.0 |
|
| Schedule of option activity |
A summary of option activity under our stock plans during the three months ended March 31, 2024 is presented below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Stock Awards Plans | | Director Stock Option Plans | | Options | | Weighted Average Exercise Price | | Options | | Weighted Average Exercise Price | | Outstanding, January 1, 2024 | 2,182,784 | | | $ | 80.63 | | | 19,000 | | | $ | 66.59 | | | Granted | 249,663 | | | 141.00 | | | — | | | — | | | Exercised | (299,595) | | | 70.69 | | | (19,000) | | | 66.59 | | | Forfeited or expired | (4,716) | | | 90.72 | | | — | | | — | | | Outstanding at March 31, 2024 | 2,128,136 | | | $ | 89.09 | | | — | | | $ | — | | | Exercisable at March 31, 2024 | 1,671,615 | | | $ | 77.98 | | | — | | | $ | — | | | Weighted-Average Remaining Contractual Term (Years): | | | | | | | | | Outstanding at March 31, 2024 | 4.3 | | | | 0.0 | | | | Exercisable at March 31, 2024 | 2.9 | | | | 0.0 | | | | Aggregate Intrinsic Value: | | | | | | | | | Outstanding at March 31, 2024 | $ | 116,617 | | | | | $ | — | | | | | Exercisable at March 31, 2024 | $ | 110,182 | | | | | $ | — | | | | Intrinsic Value of Options Exercised During the Three Months Ended: | | | | | | | | | March 31, 2024 | $ | 19,529 | | | | | $ | 1,394 | | | | | March 31, 2023 | $ | 10,118 | | | | | $ | 218 | | | |
|
| Schedule of compensation expense, and fair value related to options |
| | | | | | | | | | | | | Three Months Ended March 31, | 2024 | | 2023 | | Compensation expense (included in SG&A) | $ | 3,852 | | | $ | 2,734 | | | Compensation expense (included in Cost of sales) | 439 | | | 237 | | | Compensation expense, Total | $ | 4,291 | | | $ | 2,971 | | | Compensation expense, net of tax | 3,744 | | | 2,971 | | | Grant date fair value of options vested | 2,299 | | | — | |
|